SCHEMBL20073988

SCHEMBL20073988

CC12CCC3C(CC1=O)C32C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
PTPN1 P18031 2/20 0.41
CYP19A1 P11511 10/20 0.35
AKR1B10 O60218 1/20 0.33
AKR1B1 P15121 1/20 0.33
OR51E2 Q9H255 1/20 0.33
PTPN2 P17706 1/20 0.33
SHBG P04278 1/20 0.31
SERPINA6 P08185 1/20 0.31
GUSB P08236 1/20 0.31
CYP3A4 P08684 1/20 0.31
G6PD P11413 1/20 0.31
PMP22 Q01453 1/20 0.31
GPBAR1 Q8TDU6 1/20 0.31
TSHR P16473 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Camphor SCHEMBL1151878 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL15542393 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL2037672 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL285280 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL13248606 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL16068 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL16582770 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
(-)-Camphor SCHEMBL1701376 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL1712401 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT
Camphor SCHEMBL29673264 0.68 ALDH1A1 (1.00) KMT2AMEN1LMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208048-B2 RSV antiviral pyrazolo- and triazolo-pyrimidine compounds JANSSEN SCIENCES IRELAND UC (IE) 2019-02-19 US disclosed
US-20180105529-A1 RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS JANSSEN SCIENCES IRELAND UC (IE) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208048-B2 RSV antiviral pyrazolo- and triazolo-pyrimidine compounds ZC3HAV1, MAVS, TYMP KMT2A 4144/4885MEN1 4788/4885LMNA 3900/4885
US-20180105529-A1 RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS ZC3HAV1, MAVS, TYMP KMT2A 4144/4885MEN1 4788/4885LMNA 3900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.